Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-09-01Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-08-06Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-08-06Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand MechanismClinicalTrials.gov · 2026-08-06Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2026-08-05Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsBehavioural Pharmacology · 2026-08-01Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical TrialClinicalTrials.gov · 2026-07-30Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical TrialClinicalTrials.gov · 2026-07-30Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-07-28Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitationsBritish Journal of Clinical Pharmacology · 2026-07-21A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of PsilocybinClinicalTrials.gov · 2026-07-17Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition - Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)Zenodo (CERN European Organization for Nuclear Research) · 2026-07-14Psilocybin-induced behavioral and cellular effectsJournal of Neurogenetics · 2026-07-12PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical TrialClinicalTrials.gov · 2026-07-10Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-09Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-09A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-07-06Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-01Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label TrialClinicalTrials.gov · 2026-06-26Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-23Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.Journal of psychopharmacology (Oxford, England) · 2026-06-23Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-22Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developmentsJournal of Psychedelic Studies · 2026-06-12Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-09Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-06-09Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-06-04The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.Cureus · 2026-06-01Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman SpectroscopyJournal of Raman Spectroscopy · 2026-05-28Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportFrontiers in Neuroscience · 2026-05-28Catatonia Associated With First-Time Psilocybin Exposure: A Case ReportCureus · 2026-05-27Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intakeJournal of Analytical Toxicology · 2026-05-23Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolenceClinicalTrials.gov · 2026-05-14Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-07Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled TrialClinicalTrials.gov · 2026-05-01Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-05-01Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-05-01Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanismsNeuropharmacology · 2026-05-01Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-05-01“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-24Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted PsychotherapyClinicalTrials.gov · 2026-04-22Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain ConnectivitymedRxiv · 2026-04-20Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-18Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-15Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online surveyJournal of Psychedelic Studies · 2026-04-15A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-14Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.Acta neuropsychiatrica · 2026-04-10Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-0326-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORTJACC · 2026-04-01Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.Community mental health journal · 2026-04-01Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.Pharmacology research & perspectives · 2026-04-01Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in DepressionClinicalTrials.gov · 2026-03-30Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronseLife · 2026-03-27Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Psychedelics in functional disorders: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2026-03-20Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.International journal of molecular sciences · 2026-03-20Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Public attitudes diverge sharply on legal use of psychedelicsMental Health Weekly · 2026-03-02Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-03-01Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-makingInstituto Politécnico do Porto · 2026-02-27Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-25Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive ImpairmentClinicalTrials.gov · 2026-02-25Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.BJPsych open · 2026-02-16Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical TrialClinicalTrials.gov · 2026-02-12Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-ExchangeJournal of the American Society for Mass Spectrometry · 2026-02-04Acute psilocin increased cortical activity in ratFrontiers in Neuroscience · 2026-02-04Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.Neurologic clinics · 2026-02-01Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.Neuroscience and biobehavioral reviews · 2026-02-01Psilocybin and Bipolar Depression: Promise and Prudence.CNS drugs · 2026-02-01The effect of psilocin on neurotransmitters release in the claustrum and on rat behaviorPharmacological Reports · 2026-02-01Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01RAND: Microdosing surges as millions turned to psychedelics in 2025Mental Health Weekly · 2026-01-23Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20Presence of 4-Hydroxy--methyl--ethyltryptamine in Commercially Available Products.ACS omega · 2026-01-20Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-18Psilocybin for Treatment-Resistant OCD: A Randomized Controlled TrialPsyArXiv · 2026-01-15A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-01-12Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsResearch Square · 2026-01-07From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.Translational behavioral medicine · 2026-01-07The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.BMC psychology · 2026-01-02COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal ExtractJournal of the Brazilian Chemical Society · 2026-01-01Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2026-01-01Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.Annals of medicine and surgery (2012) · 2026-01-01Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.Journal of clinical psychopharmacology · 2026-01-01A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility TrialClinicalTrials.gov · 2025-12-30Microdosing Psychedelics to Improve MoodClinicalTrials.gov · 2025-12-30A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress DisorderCurrent Treatment Options in Psychiatry · 2025-12-25A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-23Allowing Similarities: Using Aldous Huxley’s Views on Mystical Experience to Assess the Import of Profound Unitive Experiences Occasioned by Psychedelic SubstancesReligions · 2025-12-22Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health TreatmentThe journal of desk research review and analysis. · 2025-12-16Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challengesAdvanced Neurology · 2025-12-04Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility StudyClinicalTrials.gov · 2025-12-04Efficacy of psilocybin on death anxiety in terminal patients: a narrative reviewProgress in Palliative Care · 2025-11-30Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover TrialPsyArXiv · 2025-11-16Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.Molecular neurobiology · 2025-11-01Emerging mechanisms of psilocybin-induced neuroplasticity.Trends in pharmacological sciences · 2025-11-01Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant EffectsFigshare · 2025-10-15A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From MethamphetamineClinicalTrials.gov · 2025-10-07Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-05Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.ACS chemical neuroscience · 2025-10-01Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.Journal of clinical medicine · 2025-09-19Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-13Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory.Journal of holistic nursing: official journal of the American Holistic Nurses' Association · 2025-09-03Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Journal of psychopharmacology (Oxford, England) · 2025-09-01A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.ACS pharmacology & translational science · 2025-08-08Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.International journal of molecular sciences · 2025-08-07694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATINGThe international journal of neuropsychopharmacology · 2025-08-01Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders:.Psychedelic medicine (New Rochelle, N.Y.) · 2025-08-01Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.Journal of eating disorders · 2025-07-24Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-18Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.Journal of analytical toxicology · 2025-07-014-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.Addiction biology · 2025-07-01Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.Translational psychiatry · 2025-06-14Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.The international journal of neuropsychopharmacology · 2025-06-06The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.Psychiatry research · 2025-06-01Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.Indian journal of microbiology · 2025-06-01Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signalingInternational Immunopharmacology · 2025-06-01A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety DisorderClinicalTrials.gov · 2025-05-13Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case seriesCephalalgia Reports · 2025-05-01Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.European journal of anaesthesiology · 2025-05-01Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.Drug safety · 2025-05-01Psychedelics in the treatment of cluster headachesKlinická farmakologie a farmacie · 2025-04-29Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.Biology direct · 2025-04-10Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative CareRevista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online · 2025-04-03Psilocybin has a narrow therapeutic window as an antidepressant treatment.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disordersEuropean Psychiatry · 2025-04-01Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de ArgentinaBoletín de la Sociedad Argentina de Botánica · 2025-04-01Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAINClinicalTrials.gov · 2025-03-30LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept StudyClinicalTrials.gov · 2025-03-19Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.Neuropharmacology · 2025-03-15BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIALJournal of Microbiology Biotechnology and Food Sciences · 2025-03-13Psychedelics for Substance Use Disorders: Updates for the Psychiatric TraineeAmerican Journal of Psychiatry Residents Journal · 2025-03-06Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-15Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.Journal of psychoactive drugs · 2025-02-13Psychedelic Information TheoryProceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI · 2025-02-06The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.Medicina (Kaunas, Lithuania) · 2025-02-06Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.Expert opinion on drug discovery · 2025-02-03Study finds encouraging results in psilocybin treatment for TRD patientsMental Health Weekly · 2025-01-10Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.Current pain and headache reports · 2025-01-07Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A ReceptorBook of Proceedings · 2025-01-01Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Clinical neuropharmacology · 2025-01-01Behavioral Neurobiology of Alcohol Addiction: A Decade of Great Challenges, New Hopes, and Hypes.Current topics in behavioral neurosciences · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.Frontiers in pharmacology · 2025-01-01Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.Journal of clinical psychopharmacology · 2025-01-01Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health NurseSaudi Journal of Medicine and Public Health · 2024-12-31Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified ElectrodeLetters in Applied NanoBioScience · 2024-12-30The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.CNS spectrums · 2024-12-01